Business Description
Medrx Co Ltd
ISIN : JP3921220004
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.98 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 52.92 | |||||
Beneish M-Score | 0.18 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -50.7 | |||||
3-Year EBITDA Growth Rate | 26.6 | |||||
3-Year EPS without NRI Growth Rate | 27.6 | |||||
3-Year FCF Growth Rate | 25.3 | |||||
3-Year Book Growth Rate | -23.1 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 13.4 | |||||
9-Day RSI | 28.04 | |||||
14-Day RSI | 35.15 | |||||
6-1 Month Momentum % | -41.94 | |||||
12-1 Month Momentum % | -40 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 52.58 | |||||
Quick Ratio | 52.29 | |||||
Cash Ratio | 51.13 | |||||
Days Sales Outstanding | 17.49 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.4 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -232.46 | |||||
Net Margin % | -201.52 | |||||
FCF Margin % | -359.99 | |||||
ROE % | -25.27 | |||||
ROA % | -24.35 | |||||
ROIC % | -184.98 | |||||
ROC (Joel Greenblatt) % | -293.58 | |||||
ROCE % | -28.82 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 14.51 | |||||
PB Ratio | 1.49 | |||||
Price-to-Tangible-Book | 1.48 | |||||
EV-to-EBIT | -2.73 | |||||
EV-to-EBITDA | -2.73 | |||||
EV-to-Revenue | 6.37 | |||||
EV-to-FCF | -1.97 | |||||
Price-to-Median-PS-Value | 0.1 | |||||
Price-to-Net-Current-Asset-Value | 1.69 | |||||
Price-to-Net-Cash | 1.74 | |||||
Earnings Yield (Greenblatt) % | -36.56 | |||||
FCF Yield % | -23.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medrx Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 254.049 | ||
EPS (TTM) (円) | -13.649 | ||
Beta | 1.17 | ||
Volatility % | 65.82 | ||
14-Day RSI | 35.15 | ||
14-Day ATR (円) | 3.029391 | ||
20-Day SMA (円) | 90.1 | ||
12-1 Month Momentum % | -40 | ||
52-Week Range (円) | 80 - 199 | ||
Shares Outstanding (Mil) | 45.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medrx Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medrx Co Ltd Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Medrx Co Ltd Frequently Asked Questions
What is Medrx Co Ltd(TSE:4586)'s stock price today?
When is next earnings date of Medrx Co Ltd(TSE:4586)?
Does Medrx Co Ltd(TSE:4586) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |